A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors
Clinical trial NCT05229497 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05229497
- Sponsor
- Akeso
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-04
- Primary completion
- 2026-12-31
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.